NVAX Stock – Novavax Inc. stock falls Tuesday, underperforms market
Shares of Novavax Inc.
slipped 0.25% to $173.32 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index
falling 0.11% to 13,045.39 and Dow Jones Industrial Average
falling 0.31% to 33,066.96. This was the stock’s second consecutive day of losses. Novavax Inc. closed $158.36 short of its 52-week high ($331.68), which the company achieved on February 9th.
The stock underperformed when compared to some of its competitors Tuesday, as Replimune Group Inc.
rose 0.73% to $31.57, VBI Vaccines Inc.
rose 1.37% to $2.95, and AnaptysBio Inc.
rose 2.07% to $20.23. Trading volume (1.9 M) remained 2.8 million below its 50-day average volume of 4.7 M.